Access cutting-edge coronary artery disease treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.
Access coronary artery disease specialists in Pittsburgh at no cost
This study follows strict safety protocols and ethical guidelines
All study-related coronary artery disease treatment provided free
This a Phase 3, prospective, open-label, multicenter study of \[15-O\]-H2O injection for PET imaging of subjects with suspected CAD. Approximately 182 evaluable participants with suspected CAD referred for testing will be included in the study at approximately 10 study sites in the United States and Europe. Approximately 215 participants will be enrolled to account for an estimated 15% drop-out rate. Screening assessments will occur prior to enrollment to confirm eligibility. All participants wi
Sponsor: MedTrace Pharma A/S
Check if you qualify for this coronary artery disease clinical trial in Pittsburgh, PA
If you're searching for coronary artery disease treatment options in Pittsburgh, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced coronary artery disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.